92 related articles for article (PubMed ID: 31359385)
1. Proteomics to Predict Loss of RXR-γ During Progression of Epithelial Ovarian Cancer.
Kalra RS; Bapat SA
Methods Mol Biol; 2019; 2019():1-14. PubMed ID: 31359385
[TBL] [Abstract][Full Text] [Related]
2. Expression proteomics predicts loss of RXR-γ during progression of epithelial ovarian cancer.
Kalra RS; Bapat SA
PLoS One; 2013; 8(8):e70398. PubMed ID: 23936423
[TBL] [Abstract][Full Text] [Related]
3. [Identification of metastasis-associated proteins of ovarian cancer by proteomics].
Zhou L; Yang XF; Wang Y; Zhang YT; Geng YP; Si LS; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):814-8. PubMed ID: 18346353
[TBL] [Abstract][Full Text] [Related]
4. Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.
Zhu Y; Cai L; Guo J; Chen N; Yi X; Zhao Y; Cai J; Wang Z
Tumour Biol; 2016 Oct; 37(10):14009-14023. PubMed ID: 27492604
[TBL] [Abstract][Full Text] [Related]
5. Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer.
Smith-Beckerman DM; Fung KW; Williams KE; Auersperg N; Godwin AK; Burlingame AL
Mol Cell Proteomics; 2005 Feb; 4(2):156-68. PubMed ID: 15591324
[TBL] [Abstract][Full Text] [Related]
6. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
[TBL] [Abstract][Full Text] [Related]
7. MALDI-Imaging for Classification of Epithelial Ovarian Cancer Histotypes from a Tissue Microarray Using Machine Learning Methods.
Klein O; Kanter F; Kulbe H; Jank P; Denkert C; Nebrich G; Schmitt WD; Wu Z; Kunze CA; Sehouli J; Darb-Esfahani S; Braicu I; Lellmann J; Thiele H; Taube ET
Proteomics Clin Appl; 2019 Jan; 13(1):e1700181. PubMed ID: 30471200
[TBL] [Abstract][Full Text] [Related]
8. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition.
Han W; Zhang Y; Niu C; Guo J; Li J; Wei X; Jia M; Zhi X; Yao L; Meng D
Cancer Lett; 2019 Mar; 445():45-56. PubMed ID: 30654010
[TBL] [Abstract][Full Text] [Related]
9. Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology.
Chow SN; Chen RJ; Chen CH; Chang TC; Chen LC; Lee WJ; Shen J; Chow LP
Eur J Gynaecol Oncol; 2010; 31(1):55-62. PubMed ID: 20349782
[TBL] [Abstract][Full Text] [Related]
10. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
[TBL] [Abstract][Full Text] [Related]
11. Comparing SILAC and two-dimensional gel electrophoresis image analysis for profiling urokinase plasminogen activator signaling in ovarian cancer cells.
Uitto PM; Lance BK; Wood GR; Sherman J; Baker MS; Molloy MP
J Proteome Res; 2007 Jun; 6(6):2105-12. PubMed ID: 17472359
[TBL] [Abstract][Full Text] [Related]
12. Detection of Epithelial Ovarian Cancer using C8Magnetic Bead Separation and MALDI-TOF Plasma Proteome Profiling in Egyptian Females.
Rizk MM; Sharaki OA; Meleis ME; Younan DN; Elkial AA; Moez P
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3603-3609. PubMed ID: 31870100
[TBL] [Abstract][Full Text] [Related]
13. Protein expression changes in ovarian cancer during the transition from benign to malignant.
Waldemarson S; Krogh M; Alaiya A; Kirik U; Schedvins K; Auer G; Hansson KM; Ossola R; Aebersold R; Lee H; Malmström J; James P
J Proteome Res; 2012 May; 11(5):2876-89. PubMed ID: 22471520
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.
Qu H; Chen Y; Cao G; Liu C; Xu J; Deng H; Zhang Z
Oncotarget; 2016 Dec; 7(50):83187-83199. PubMed ID: 27825122
[TBL] [Abstract][Full Text] [Related]
15. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
Gao C; Yao H; Liu H; Feng Y; Yang Z
BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464
[TBL] [Abstract][Full Text] [Related]
16. Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.
Zhang Q; Zhou W; Yu S; Ju Y; To SKY; Wong AST; Jiao Y; Poon TCW; Tam KY; Lee LTO
Oncogene; 2021 Jan; 40(1):97-111. PubMed ID: 33082557
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
18. The functional proteomics analysis of VEGF-treated human epithelial ovarian cancer cells.
Zhang F; Li C; Liu H; Wang Y; Chen Y; Wu X
Tumour Biol; 2014 Dec; 35(12):12379-87. PubMed ID: 25192722
[TBL] [Abstract][Full Text] [Related]
19. CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway.
Shen F; Zong ZH; Liu Y; Chen S; Sheng XJ; Zhao Y
Biomed Pharmacother; 2019 Jun; 114():108787. PubMed ID: 30925458
[TBL] [Abstract][Full Text] [Related]
20. CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182.
Zong ZH; Du YP; Guan X; Chen S; Zhao Y
J Exp Clin Cancer Res; 2019 Oct; 38(1):437. PubMed ID: 31666098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
